Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fortress Biotech, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.335 Ladies and gentlemen, thank you for standing by. 00:00:02.335 -- 00:00:07.743 Good afternoon and welcome to Journey Medical's third quarter 2025 financial results 00:00:07.743 -- 00:00:12.671 and corporate update conference call. At this time, all participants will be in a listen-only 00:00:12.671 -- 00:00:16.697 mode. Should you need assistance, please signal conference specialist by pressing the 00:00:16.697 -- 00:00:19.742 star key followed by zero. 00:00:19.742 -- 00:00:23.828 Participants of this call are advised that the audio of this call is being broadcast 00:00:23.828 -- 00:00:28.263 live over the internet and is also being recorded for playback purposes. 00:00:28.263 -- 00:00:33.409 A webcast replay of this call will be available approximately one hour after the call 00:00:33.409 -- 00:00:37.834 for approximately 30 days. I would now like to turn the call over to Ms. 00:00:37.834 -- 00:00:41.699 Jacqueline Jaffe, the company's senior director of corporate operations. 00:00:41.699 -- 00:00:43.841 Please go ahead, Jacqueline. 00:00:43.841 -- 00:00:48.126 Good afternoon, and thank you for participating in today's conference call. 00:00:48.126 -- 00:00:53.453 Joining me from Journey Medical's leadership team are Claude Morali, co-founder, president, 00:00:53.453 -- 00:00:58.165 and chief executive officer, and Joseph Benesch, chief financial officer. 00:00:58.165 -- 00:01:03.151 Joining for the Q&A portion of the call will be Ramzi Aloush, Chief Operating Officer 00:01:03.151 -- 00:01:08.577 and General Counsel. During this call, management will be making forward-looking statements, 00:01:08.577 -- 00:01:12.862 including statements that address, among other things, Journey Medical's expectations 00:01:12.862 -- 00:01:17.908 f...